Reports - Obesity Treatment Market
HealthcareObesity Treatment Market
Obesity Treatment Market Size | Industry Report, 2035 by Surgery (Adjusting gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy, Biliopancreatic diversion with Duodenal Switch), by Drugs (Appetite suppressants, Combination drugs, Malabsorption, Satiety drugs), by Region (North America, Europe, Asia Pacific, Latin America
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Obesity Treatment Market - Segment Analysis
1. Overview
2. Global Obesity Treatment Market, 2021 - 2035 (USD Million)
3. Global Obesity Treatment Market - by Surgery
3.1. By Adjusting gastric Banding
3.2. By Roux-en-Y Gastric Bypass
3.3. By Sleeve gastrectomy
3.4. By Biliopancreatic diversion with Duodenal Switch
3.5. By Endoscopic Procedures
4. Global Obesity Treatment Market - by Drugs
4.1. By Appetite suppressants
4.2. By Combination drugs
4.3. By Malabsorption
4.4. By Satiety drugs
5. Global Obesity Treatment Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Obesity Treatment Market - Segment Analysis
1. Overview
2. North America Obesity Treatment Market, 2021 - 2035 (USD Million)
3. North America Obesity Treatment Market - by Surgery
3.1. By Adjusting gastric Banding
3.2. By Roux-en-Y Gastric Bypass
3.3. By Sleeve gastrectomy
3.4. By Biliopancreatic diversion with Duodenal Switch
3.5. By Endoscopic Procedures
4. North America Obesity Treatment Market - by Drugs
4.1. By Appetite suppressants
4.2. By Combination drugs
4.3. By Malabsorption
4.4. By Satiety drugs
Chapter 5 Europe Obesity Treatment Market - Segment Analysis
1. Overview
2. Europe Obesity Treatment Market, 2021 - 2035 (USD Million)
3. Europe Obesity Treatment Market - by Surgery
3.1. By Adjusting gastric Banding
3.2. By Roux-en-Y Gastric Bypass
3.3. By Sleeve gastrectomy
3.4. By Biliopancreatic diversion with Duodenal Switch
3.5. By Endoscopic Procedures
4. Europe Obesity Treatment Market - by Drugs
4.1. By Appetite suppressants
4.2. By Combination drugs
4.3. By Malabsorption
4.4. By Satiety drugs
Chapter 6 Asia Pacific Obesity Treatment Market - Segment Analysis
1. Overview
2. Asia Pacific Obesity Treatment Market, 2021 - 2035 (USD Million)
3. Asia Pacific Obesity Treatment Market - by Surgery
3.1. By Adjusting gastric Banding
3.2. By Roux-en-Y Gastric Bypass
3.3. By Sleeve gastrectomy
3.4. By Biliopancreatic diversion with Duodenal Switch
3.5. By Endoscopic Procedures
4. Asia Pacific Obesity Treatment Market - by Drugs
4.1. By Appetite suppressants
4.2. By Combination drugs
4.3. By Malabsorption
4.4. By Satiety drugs
Chapter 7 Latin America Obesity Treatment Market - Segment Analysis
1. Overview
2. Latin America Obesity Treatment Market, 2021 - 2035 (USD Million)
3. Latin America Obesity Treatment Market - by Surgery
3.1. By Adjusting gastric Banding
3.2. By Roux-en-Y Gastric Bypass
3.3. By Sleeve gastrectomy
3.4. By Biliopancreatic diversion with Duodenal Switch
3.5. By Endoscopic Procedures
4. Latin America Obesity Treatment Market - by Drugs
4.1. By Appetite suppressants
4.2. By Combination drugs
4.3. By Malabsorption
4.4. By Satiety drugs
Chapter 8 Middle East & Africa Obesity Treatment Market - Segment Analysis
1. Overview
2. Middle East & Africa Obesity Treatment Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Obesity Treatment Market - by Surgery
3.1. By Adjusting gastric Banding
3.2. By Roux-en-Y Gastric Bypass
3.3. By Sleeve gastrectomy
3.4. By Biliopancreatic diversion with Duodenal Switch
3.5. By Endoscopic Procedures
4. Middle East & Africa Obesity Treatment Market - by Drugs
4.1. By Appetite suppressants
4.2. By Combination drugs
4.3. By Malabsorption
4.4. By Satiety drugs
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. VIVUS Inc. (US)
2. Arena Pharmaceuticals Inc. (US)
3. F. Hoffmann-La Roche Ltd. (Switzerland)
4. Novo Nordisk A/S (Denmark)
5. Allergan Plc (US)
6. Medtronic (US)
7. Ethicon (a subsidiary of Johnson & Johnson) (US)
8. Cousin Biotech (France)
9. EnteroMedics Inc. (US)
10. and USGI Medical Inc. (US).
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By